A high-performance DNS stub resolver for bulk lookups and reconnaissance (subdomain enumeration)
- dns
- dns-resolver
- dns-resolution
- dns-bruteforcer
132,241 visible repositories in the index
25–48 of 179 · Most stars
A high-performance DNS stub resolver for bulk lookups and reconnaissance (subdomain enumeration)
A fast sub domain brute tool for pentesters
一款适用于以HW行动/红队/渗透测试团队为场景的移动端(Android、iOS、WEB、H5、静态网站)信息收集扫描工具,可以帮助渗透测试工程师、攻击队成员、红队成员快速收集到移动端或者静态WEB站点中关键的资产信息并提供基本的信息输出,如:Title、Domain、CDN、指纹信息、状态信息等。
Six Degrees of Domain Admin
A DNS meta-query spider that enumerates DNS records, and subdomains.
RNA vaccines have become a key tool in moving forward through the challenges raised both in the current pandemic and in numerous other public health and medical challenges. With the rollout of vaccines for COVID-19, these synthetic mRNAs have become broadly distributed RNA species in numerous human populations. Despite their ubiquity, sequences are not always available for such RNAs. Standard methods facilitate such sequencing. In this note, we provide experimental sequence information for the RNA components of the initial Moderna (https://pubmed.ncbi.nlm.nih.gov/32756549/) and Pfizer/BioNTech (https://pubmed.ncbi.nlm.nih.gov/33301246/) COVID-19 vaccines, allowing a working assembly of the former and a confirmation of previously reported sequence information for the latter RNA. Sharing of sequence information for broadly used therapeutics has the benefit of allowing any researchers or clinicians using sequencing approaches to rapidly identify such sequences as therapeutic-derived rather than host or infectious in origin. For this work, RNAs were obtained as discards from the small portions of vaccine doses that remained in vials after immunization; such portions would have been required to be otherwise discarded and were analyzed under FDA authorization for research use. To obtain the small amounts of RNA needed for characterization, vaccine remnants were phenol-chloroform extracted using TRIzol Reagent (Invitrogen), with intactness assessed by Agilent 2100 Bioanalyzer before and after extraction. Although our analysis mainly focused on RNAs obtained as soon as possible following discard, we also analyzed samples which had been refrigerated (~4 ℃) for up to 42 days with and without the addition of EDTA. Interestingly a substantial fraction of the RNA remained intact in these preparations. We note that the formulation of the vaccines includes numerous key chemical components which are quite possibly unstable under these conditions-- so these data certainly do not suggest that the vaccine as a biological agent is stable. But it is of interest that chemical stability of RNA itself is not sufficient to preclude eventual development of vaccines with a much less involved cold-chain storage and transportation. For further analysis, the initial RNAs were fragmented by heating to 94℃, primed with a random hexamer-tailed adaptor, amplified through a template-switch protocol (Takara SMARTerer Stranded RNA-seq kit), and sequenced using a MiSeq instrument (Illumina) with paired end 78-per end sequencing. As a reference material in specific assays, we included RNA of known concentration and sequence (from bacteriophage MS2). From these data, we obtained partial information on strandedness and a set of segments that could be used for assembly. This was particularly useful for the Moderna vaccine, for which the original vaccine RNA sequence was not available at the time our study was carried out. Contigs encoding full-length spikes were assembled from the Moderna and Pfizer datasets. The Pfizer/BioNTech data [Figure 1] verified the reported sequence for that vaccine (https://berthub.eu/articles/posts/reverse-engineering-source-code-of-the-biontech-pfizer-vaccine/), while the Moderna sequence [Figure 2] could not be checked against a published reference. RNA preparations lacking dsRNA are desirable in generating vaccine formulations as these will minimize an otherwise dramatic biological (and nonspecific) response that vertebrates have to double stranded character in RNA (https://www.nature.com/articles/nrd.2017.243). In the sequence data that we analyzed, we found that the vast majority of reads were from the expected sense strand. In addition, the minority of antisense reads appeared different from sense reads in lacking the characteristic extensions expected from the template switching protocol. Examining only the reads with an evident template switch (as an indicator for strand-of-origin), we observed that both vaccines overwhelmingly yielded sense reads (>99.99%). Independent sequencing assays and other experimental measurements are ongoing and will be needed to determine whether this template-switched sense read fraction in the SmarterSeq protocol indeed represents the actual dsRNA content in the original material. This work provides an initial assessment of two RNAs that are now a part of the human ecosystem and that are likely to appear in numerous other high throughput RNA-seq studies in which a fraction of the individuals may have previously been vaccinated. ProtoAcknowledgements: Thanks to our colleagues for help and suggestions (Nimit Jain, Emily Greenwald, Lamia Wahba, William Wang, Amisha Kumar, Sameer Sundrani, David Lipman, Bijoyita Roy). Figure 1: Spike-encoding contig assembled from BioNTech/Pfizer BNT-162b2 vaccine. Although the full coding region is included, the nature of the methodology used for sequencing and assembly is such that the assembled contig could lack some sequence from the ends of the RNA. Within the assembled sequence, this hypothetical sequence shows a perfect match to the corresponding sequence from documents available online derived from manufacturer communications with the World Health Organization [as reported by https://berthub.eu/articles/posts/reverse-engineering-source-code-of-the-biontech-pfizer-vaccine/]. The 5’ end for the assembly matches the start site noted in these documents, while the read-based assembly lacks an interrupted polyA tail (A30(GCATATGACT)A70) that is expected to be present in the mRNA.
MailSniper is a penetration testing tool for searching through email in a Microsoft Exchange environment for specific terms (passwords, insider intel, network architecture information, etc.). It can be used as a non-administrative user to search their own email, or by an administrator to search the mailboxes of every user in a domain.
All In One Web Recon
JSFinder is a tool for quickly extracting URLs and subdomains from JS files on a website.
This is an Open source intelligent framework ie an osint tool which gathers valid information about a phone number, user's email address, perform VIN Osint, and reverse, perform subdomain enumeration, able to find email from a name, and so much more. Best osint tool for Termux and linux
**NOT MAINTAINED** Two-factor authentication for Node.js. One-time passcode generator (HOTP/TOTP) with support for Google Authenticator.
Th3Inspector 🕵️ Best Tool For Information Gathering 🔎
ScopeSentry-Cyberspace mapping, subdomain enumeration, port scanning, sensitive information discovery, vulnerability scanning, distributed nodes
Generates permutations, alterations and mutations of subdomains and then resolves them
Activation & Lifecycle State Maintenance Toolkit
An easy-to-setup version of XSS Hunter. Sets up in five minutes and requires no maintenance!
域名SSL证书监测平台、SSL证书申请自动续签。Domain and SSL Cert monitor System.
Sudomy is a subdomain enumeration tool to collect subdomains and analyzing domains performing automated reconnaissance (recon) for bug hunting / pentesting
无状态子域名爆破工具
SpringBoot single sign-on authentication and authorization, implemented with OAuth 2.0, supporting cross-domain and distributed deployment.
Open-source security research tool for identifying origin IP exposure of websites protected by Cloudflare and similar reverse proxy services.
Puredns is a fast domain resolver and subdomain bruteforcing tool that can accurately filter out wildcard subdomains and DNS poisoned entries.
dnsReaper - subdomain takeover tool for attackers, bug bounty hunters and the blue team!
Attack Graph Visualizer and Explorer (Active Directory) ...Who's *really* Domain Admin?